Alvar J,Vélez ID,Bern C,Herrero M,Desjeux P,Cano J .2012 .Leishmaniasis worldwide and global estimates of its incidence. PLoS One, 7(5) : e35671.
Ashford RW,Bern C,Boelaert M,Bryceson A,Chappuis F,Croft S .2008 .Control of the leishmaniases. In: World Health Organization - Technical Report Series, : .
Burza S,Croft SL,Boelaert M.,Leishmaniasis M. .2018 .. , 392(10151) : 951-70.
Markle WH,Makhoul K. .2004 .Cutaneous leishmaniasis: Recognition and treatment. Am Fam Physician, 69(6) : 1455-60.
Vega-López F .2003 .Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis, 16(2) : 97-101.
Elmahallawy EK,Sampedro Martínez A,Rodriguez-Granger J,Hoyos-Mallecot Y,Agil A,Navarro Mari JM .2014 .Diagnosis of leishmaniasis. J Infect Dev Ctries, 8(8) : 961-71.
Rogers ME,Ilg T,Nikolaev A V,Ferguson MAJ,Bates PA .2004 .Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature, 430(6998) : 463-7.
Georgiadou SP,Makaritsis KP,Dalekos GN .2015 .Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment. J Transl Intern Med, 3(2) : 43-50.
Yesilova Y,Surucu HA,Ardic N,Aksoy M,Yesilova A,Oghumu S .2016 .Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. J Dermatal Treat, 27(1) : 83-7.
Minodier P,Parola P .2007 .Cutaneous leishmaniasis treatment. Travel Med Infect Dis, 5(3) : 150-8.
Croft SL,Seifert K,Yardley V .2006 .Current scenario of drug development for leishmaniasis. Indian J Med Res, 123(3) : 399-410.
Nieto J,Alvar J,Mullen AB,Carter KC,Rodríguez C,Andre MIS .2003 .Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals. Antimicrob Agents Chemother, 47(9) : 2781-7.
Khan K,Khan AU,Khan A,Khan M,Ahmad I. .2020 .Fractionated illumination improves the treatment outcomes of photodynamic therapy for high grade cutaneous leishmaniasis. Photodiagnosis Photodyn Ther, 29 : 101622.
Khan K,Khan AU,Gul B,Ullah A,Khan M,Ahmad I. .2021 .Photodynamic therapy for the treatment of cutaneous: a case series from Pakistan. Eur J Med Case Reports, 5(7) : 203-8.
Khan K,Khan AU,Ullah A,Khan M,Ahmad I .2020 .Low‐level laser therapy for the treatment of early stage cutaneous leishmaniasis: A pilot study. Dermatol Ther, 33(6) : e14232.
Al-Natour SH .1994 .Update in the treatment of cutaneous leishmaniasis. J Fam Community Med, 16(2) : 41-7.
Farooq M,Farooq MS,Bari AU,Malik TM .2021 .Comparison of oral chloroquine with systemic meglumine antimoniate in treatment of cutaneous leishmaniasis. Pakistan Armed Forces Med, 71(1) : 139-44.
Yasmin R,Khan I,Ahmad SA .2011 .Response to treatment of cutaneous leishmaniasis with intralesional chloroquine vs intralesional meglumine antimoniate. J Pakistan Assoc Dermatol, 21(4) : 270-5.
Hanif MM,Akram K,Mustafa G .2016 .Intralesional versus oral chloroquine in cutaneous leishmaniasis: Comparison of outcome, duration of treatment and total dose of drug. J Coll Physicians Surg Pakistan, 26(4) : 260-2.
Kip AE,Balasegaram M,Beijnen JH,Schellens JHM .2015 .Systematic review of biomarkers to monitor therapeutic response in leishmaniasis. Antimicrob Agents Chemother, 59(1) : 1-14.
Gonzalez U,Pinart M,Reveiz L,Rengifopardo M,Tweed J,Macaya A .2010 .Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. Clin Infect Dis, 51(4) : 409-19.
Yesilova Y,Surucu HA,Ardic N,Aksoy M,Yesilova A,Oghumu S .2016 .Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. J Dermatolog Treat, 27 : 83-7.
Brito NC,Rabello A,Cota GF .2017 .Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PLoS One, 12(9) : e0184777.
Bashir U,Tahir M,Anwar MI,Manzoor F .2019 .Comparison of intralesional meglumine antimonite along with oral itraconazole to intralesional meglumine antimonite in the treatment of cutaneous leishmaniasis. Pakistan J Med Sci, 35(6) : 1669-73.
Banihashemi M,Yazdanpanah MJ,Amirsolymani H,Yousefzadeh H H .2015 .Comparison of lesion improvement in lupoid leishmaniasis patients with two treatment approaches: Trichloroacetic acid and intralesional meglumine antimoniate. J Cutan Med Surg, 19 : 35-9.
Nilforoushzadeh MA,Siadat AH,Ansari N,Haftbaradaran E,Ahmadi E. .2013 .A comparison between the effects of glucantime, topical trichloroacetic acid 50% plus glucantime, and fractional laser plus glucantime on cutaneous leishmaniasis lesions. J Isfahan Med Sch, 30(221) : 2450-9.
Gupta S,Jain VK,Aggarwal K. .2005 .Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Int J Dermatol, 44 : 1064-5.
Uzun S,Durdu M,Culha G,Allahverdiyev AM,Memisoglu HR. .2004 .Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: Recent experience in Turkey. J Parasitol, 90(4) : 853-9.
Faghihi G,Tavakoli-kia R G .2003 .Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clin Exp Dermatol, 28 : 13-6.
Asilian A,Sadeghinia A .2004 .A. of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®). Int J Dermatol, 43 : 281-3.
Ferreira E Vasconcellos ÉDC,Fernandes Pimentel MI,De Oliveira Schubach A,Carvalhaes De Oliveira RDV,AzeredoCoutinho RB,Da Conceição Silva F RB .2012 .Short report: Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (. Am J Trop Med Hyg, 87(2) : 257-60.
Sadeghian G,Nilfroushzadeh MA .2007 .Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol, 32(4) : 371-4.
Asilian A,Sadeghinia A,Faghihi G,Momeni A,Amini Harandi A. .2003 .The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Ann Trop Med Parasitol, 97(5) : 493-8.
Alkhawajah AM,Larbi E,Al-Gindan Y,Abahussein A,Jain S. .1997 .Treatment of cutaneous leishmaniasis with antimony: Intramuscular versus intralesional administration. Ann Trop Med Parasitol, 91(8) : 899-905.